Intrinsiqq
Tyra Biosciences, Inc. logo

Tyra Biosciences, Inc. Insider Trading

TYRA

Compare
Last 12 months

Insiders bought 20K and sold $1.45M on the open market.

64% of the selling was scheduled in advance under 10b5-1 plans. Director Gilla Kaplan sold 528K on Mar 25, 34% of their stake, outside a plan.

Net open-market
−$1.43M
1 buy · 5 sales
Under a 10b5-1 plan
64%
of the value sold
Insiders who bought / sold
1 / 3
executives and directors
Last open-market buy
Sep 2026
Sep 9, 2026

Get an email when TYRA's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Sep 9
    Rehan Verjee
    Director · bought 972 at $20.58
    20K
    New position
  • Mar 25No plan
    Gilla Kaplan
    Director · sold 14,295 at $36.97
    528K
    34% of stake
  • Feb 1210b5-1 plan
    Daniel Bensen
    Chief Discovery Officer · sold 8,000 at avg $32.87
    263K
    5.2% of stake
  • Jan 1210b5-1 plan
    Daniel Bensen
    Chief Discovery Officer · sold 8,000 at avg $28.52
    228K
    4.9% of stake
  • Dec 19, 202510b5-1 plan
    Robert J More
    Director · sold 10,000 at $25.00
    250K
    0.3% of stake
  • Dec 12, 202510b5-1 plan
    Daniel Bensen
    Chief Discovery Officer · sold 8,000 at $22.64
    181K
    4.7% of stake
  • Nov 21, 202510b5-1 plan
    Robert J More
    Director · sold 246,871 at $20.25
    $5M
    6.1% of stake
  • Nov 18, 2025 – Nov 19, 202510b5-1 plan
    Daniel Bensen
    Chief Operating Officer · sold 125,589 at avg $16.17
    $2.03M
    42% of stake
  • Nov 13, 2025 – Nov 17, 202510b5-1 plan
    Daniel Bensen
    Chief Operating Officer · sold 131,411 at avg $16.04
    $2.11M
    31% of stake
  • Jun 17, 2025 – Jun 18, 2025No plan
    Gilla Kaplan
    Director · sold 9,578 at avg $9.78
    94K
    25% of stake
  • Jun 12, 2025 – Jun 16, 2025
    RA Capital Management, L.p.
    Large holder · bought 163,287 at avg $10.19
    $1.66M
    1.6% of stake
  • Jun 12, 2025 – Jun 16, 2025No plan
    Gilla Kaplan
    Director · sold 51,814 at avg $10.32
    535K
    58% of stake
  • Jun 9, 2025
    RA Capital Healthcare Fund LP
    Large holder · bought 186,850 at $10.19
    $1.9M
    1.9% of stake
  • Jun 4, 2025 – Jun 5, 2025
    Peter Kolchinsky
    Director · bought 1,211,198 at avg $9.70
    $11.8M
    14% of stake
  • Feb 5, 2025No plan
    Nina S Kjellson
    Director · sold 5,401 at avg $13.76
    74K
    0.1% of stake
  • Jan 23, 2025No plan
    Nina S Kjellson
    Director · sold 4,825 at $16.26
    78K
    0.1% of stake
  • Jan 16, 2025 – Jan 21, 2025No plan
    Nina S Kjellson
    Director · sold 25,041 at avg $16.36
    410K
    0.3% of stake
  • Nov 25, 2024No plan
    Nina S Kjellson
    Director · sold 5,272 at avg $16.84
    89K
    0.1% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch TYRA, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with TYRA

CompareIntrinsic value
COYACoya Therapeutics Inc.
$2.95-1.01%10
ATOSAtossa Therapeutics Inc
$1.60-8.86%10
XLOXilio Therapeutics, Inc.
$7.56+0.67%50
ABUSArbutus Biopharma Corporation
$4.02-1.23%84
UPBUpstream Bio, Inc.
$1.59-20.50%21
OVIDOvid Therapeutics Inc.
$2.20-5.98%10
LQDALiquidia Corporation
$54.43-3.88%63
PCRXPacira BioSciences Inc.
$36.48+0.00%61

Held by ETFs

TYRA is in 38 US ETFs. The largest of them, with TYRA's weight in each:

Spot a number that looks wrong? Check it in TYRA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing TYRA

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.